Hangzhou Minsheng Pharmaceutical Co., Ltd.
-
Founded in:
1963-11-29 -
Country:
China -
Address:
No. 36, Linping Avenue, Donghu Street, Linping District, Hangzhou City, Zhejiang Province -
Tax NO.:
913301101430685558 -
Registered Funds:
88.97 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dideoxyinosine |
It is a nucleotide analog that can competitively participate in the synthesis of new nucleotide chains during DNA or RNA replication or reverse transcription, and terminate the continued synthesis of the chain, making it impossible for HIV RNA to be reverse transcribed or integrated into the host cell chromosome through proviral DNA, thereby inhibiting HIV reverse transcriptase activity and blocking infection.
More
It is a nucleotide analog that can competitively participate in the synthesis of new nucleotide chains during DNA or RNA replication or reverse transcription, and terminate the continued synthesis of the chain, making it impossible for HIV RNA to be reverse transcribed or integrated into the host cell chromosome through proviral DNA, thereby inhibiting HIV reverse transcriptase activity and blocking infection. |
69655-05-6 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| N-Acetyl-L-cysteine |
Acetylcysteine is a precursor of reduced glutathione (GSH) and is an oxygen free radical scavenger in the body. The mechanism of its liver protection is not very clear, but it may be related to maintaining or restoring glutathione levels. In addition, acetylcysteine may also play a liver protection role by improving hemodynamics and oxygen transport capacity and expanding microcirculation.
More
Acetylcysteine is a precursor of reduced glutathione (GSH) and is an oxygen free radical scavenger in the body. The mechanism of its liver protection is not very clear, but it may be related to maintaining or restoring glutathione levels. In addition, acetylcysteine may also play a liver protection role by improving hemodynamics and oxygen transport capacity and expanding microcirculation. |
616-91-1 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anisodamine |
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, and improve microcirculation. It has a relaxing effect on gastrointestinal smooth muscle and inhibits its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting salivary gland secretion and dilating pupils is weaker, which is 1/20 to 1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.
More
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, and improve microcirculation. It has a relaxing effect on gastrointestinal smooth muscle and inhibits its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting salivary gland secretion and dilating pupils is weaker, which is 1/20 to 1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine. |
17659-49-3 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Exemestane |
It inactivates aromatase by irreversibly binding to its active site, thereby significantly reducing the level of estrogen in the blood circulation of menopausal women and is used to treat postmenopausal hormone-dependent breast cancer.
More
It inactivates aromatase by irreversibly binding to its active site, thereby significantly reducing the level of estrogen in the blood circulation of menopausal women and is used to treat postmenopausal hormone-dependent breast cancer. |
107868-30-4 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Prozacrol hydrochloride |
This product is a β-adrenergic receptor blocker that can block myocardial β-receptors, slow down heart rate, inhibit cardiac contractility and atrioventricular conduction, reduce cardiac output and circulating blood flow, and reduce myocardial oxygen consumption; it can also reduce renin and aldosterone secretion, reduce vascular tension, reduce blood volume and lower blood pressure.
More
This product is a β-adrenergic receptor blocker that can block myocardial β-receptors, slow down heart rate, inhibit cardiac contractility and atrioventricular conduction, reduce cardiac output and circulating blood flow, and reduce myocardial oxygen consumption; it can also reduce renin and aldosterone secretion, reduce vascular tension, reduce blood volume and lower blood pressure. |
0 |